Indefinite Delivery Contract 75N98019D00059

The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $7 million indefinite delivery contract to Murty Pharmaceuticals, Inc., a small disadvantaged minority-owned business, for the development and manufacture of pharmaceutical products to support NIDA's substance abuse and addiction treatment research programs. Under this contract, Murty Pharmaceuticals performs a range of services including formulation development,...

This indefinite delivery contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to SpecGx LLC, doing business as Mallinckrodt Pharmaceuticals, a foreign-owned pharmaceutical manufacturer. The contract has a ceiling value of $4,154,058.30 and a period of performance through December 9, 2029. The contract is for the supply of Methylphenidate HCL Extended-Release Tablets in 10mg and 20mg strengths, packaged in 100-count bottles. This is a firm-fixed price,...

This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor. The contract is for the procurement of Metformin HCL IR Tablets, targeting multiple federal agencies including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers. The contract has a base period of one year with four...

The federal contract IDV award SPE2D223D0004 was granted to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The $6,044,620.00 single-award indefinite delivery contract was issued by the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency. The contract aims to establish a national supply source for Dimethyl Fumarate DR capsules in 120mg and 240mg strengths, to be purchased by Department of Defense...

The National Institute on Drug Abuse (NIDA), a civilian agency, has awarded an Indefinite Delivery Contract (IDC) valued at up to $10,000,000 to Benuvia Operations, LLC, a for-profit organization. The 5-year IDC, awarded on March 14, 2025, will provide GMP synthesis of bulk drug substances, including the synthesis of GMP psilocybin, for NIDA's toxicological and clinical trials program. The contract requires the vendor to have the capability to manufacture both GMP and non-GMP bulk drug...

The federal contract IDV SPE2D221D0130 is a single-award Indefinite Delivery Contract awarded to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business, by the Defense Logistics Agency (DLA) on June 21, 2021. The $15.9 million contract has a period of performance through June 20, 2026 and provides for the manufacture and distribution of generic pharmaceutical products including gabapentin, atorvastatin calcium, clopidogrel bisulfate, fluoxetine hydrochloride, bupropion HCL ER,...

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business. The single-award, $10,819,189.25 ceiling value contract is for the supply of various generic pharmaceutical products, including tablets and capsules containing gabapentin, atorvastatin calcium, clopidogrel bisulfate, fluoxetine hydrochloride, bupropion HCL ER, naproxen, hydralazine, and celecoxib. The...

The National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, awarded a single-award Indefinite Delivery Contract (IDC) to Polypeptide Laboratories San Diego, LLC (doing business as Polypeptide Labs) in February 2022. The $2,781,317 contract covers the synthesis and distribution of opioid and related peptides over a 5-year period of performance from February 15, 2022 to February 14, 2027. Polypeptide Labs, a specialized manufacturer of...

This single-award Indefinite Delivery Contract was issued by the Defense Logistics Agency to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The 5-year contract, valued at up to $10,967,220, aims to establish a national supply source for Rivastigmine 24HR Patches in 4.6mg, 9.5mg, and 13.3mg strengths. These transdermal patches are used to treat Alzheimer's and Parkinson's disease patients across the Department of Defense, Department of Veterans Affairs, Indian...

This indefinite delivery contract (IDC), awarded by the National Institutes of Health National Institute on Drug Abuse (NIDA) to Vitae Enim Vitae Scientific, Inc. (VEV Scientific), provides Chemistry, Manufacturing, and Control (CMC) services to support the development of drug products by the National Center for Advancing Translational Sciences (NCATS). The $49.9M, 7-year contract will deliver a range of preclinical services required for the design, development, manufacture, and release of...